参考文献/References:
[1] Montone R A,Camilli M,Calvieri C,et al.Exposome in Ischaemic Heart Disease:beyond traditional risk factors[J].Eur Heart J,2024,45(06):419-438.
[2] Solola Nussbaum S,Henry S,Yong C M,et al.Sex-specific considerations in the presentation,diagnosis,and management of Ischemic Heart Disease:JACC Focus Seminar 2/7[J].J Am Coll Cardiol,2022,
79(14):1398-1406.
[3] Diseases GBD,Injuries C.Global incidence,prevalence, years lived with disability(YLDs),disability-adjusted life-years(DALYs), and healthy life expectancy(HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet,2024,403(10440):2133-2161.
[4] Collaborators GCoD.Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet,2024,403(10440): 1988.
[5] Xie J,Wang M,Long Z,et al.Global burden of Type 2 Diabetes in adolescents and young adults,1990-2019:systematic analysis of the Global Burden of Disease Study 2019[J].BMJ,2022,379:e072385.
[6] Cheng L,Wang Z,Li R,et al.The global burden, trends and cross-country inequalities of female breast and gynaecologic cancers:a population based study[J].BJOG,2025,132(01):55-63.
[7] Celermajer D S,Chow C K,Marijon E,et al.Cardiovascular disease in the developing world:prevalences, patterns, and the potential of early disease detectio[J].J Am Coll Cardiol,2012,60(14):1207-1216.
[8] Sterpetti A V,Gabriele R,Iannone I,et al.Trends towards increase of cardiovascular diseases mortality in USA:a comparison with Europe and the importance of preventive care[J].Curr Probl Cardiol,2024,49(04):102459.
[9] Ohira T,Eguchi E,Hayashi F,et al.Epidemiology of cardiovascular disease in Japan: an overview study[J].J Cardiol,2024,83(03):191-200.
[10] Ma L Y,Wang X D,Liu S,et al.Prevalence and risk factors of stroke in a rural area of northern China:a 10-year comparative study[J].Aging Clin Exp Res,2022,34(05):1055-1063.
[11] Wang B,Li P,He F,et al.Spatiotemporal variations in Ischemic Heart Disease mortality and related risk factors in China between 2010 and 2015:a multilevel analysis[J].BMC Public Health,2021,21(01):9.
[12] Ji H,Kwan A C,Chen M T,et al.Sex differences in myocardial and vascular aging[J].Circ Res,2022,130(04):566-577.
[13] Roth G A,Mensah G A,Johnson C O,et al.Global burden of cardiovascular diseases and risk factors, 1990-2019:update from the GBD 2019 study[J].J Am Coll Cardiol,2020,76(25):2982-3021.
[14] Moran A,Gu D, Zhao D,et al.Future cardiovascular disease in China:Markov model and risk factor scenario projections from the Coronary Heart Disease policy model-China[J].Circ Cardiovasc Qual Outcomes,2010,3(03):243-252.
[15] Sliwa K, Viljoen C A,Stewart S,et al.Cardiovascular disease in low-and middle-income countries associated with environmental factors[J].Eur J Prev Cardiol,2024,31(06):688-697.
[16] Kaufman J D,Elkind M S V,Bhatnagar A,et al.Guidance to reduce the cardiovascular burden of ambient air pollutants:a policy statement from the American Heart Association[J].Circulation,2020,142(23):e432-e447.
[17] Zhang S,Routledge M N.The contribution of PM(2.5) to cardiovascular disease in China[J].Environ Sci Pollut Res Int,2020,27(30): 37502-37513.
[18] Yusuf S,Joseph P,Rangarajan S,et al.Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income,middle-income,and low-income countries (PURE):a prospective cohort study[J].Lancet,2020,395(10226):795-808.
[19] Collaborators GBDT.Spatial,temporal,and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories,1990-2019:a systematic analysis from the Global Burden of Disease Study 2019[J].Lancet,2021,397(10292):2337-2360.
[20] Du S,Wang H, Zhang B,Popkin BM.Dietary potassium intake remains low and sodium intake remains high, and most sodium is derived from home food preparation for Chinese adults,1991-2015 trends[J].J Nutr,2020, 150(05):1230-1239.
[21] Chobufo M D,Singla A,Rahman E U,et al.Temporal trends in atherosclerotic cardiovascular disease risk among U.S.adults.Analysis of the National Health and Nutrition Examination Survey,1999-2018[J].Eur J Prev Cardiol,2022,29(18):2289-2300.
相似文献/References:
[1]程亮亮,高明月,邱培媛,等.西部民族地区新农合运行现状分析[J].卫生经济研究,2016,(10):29.
[2]张礼亮,张婧怡,田佳帅,等.肺结核患者疾病负担现状及影响因素研究[J].卫生经济研究,2024,41(05):36.
ZHANG Liliang,ZHANG Jingyi,TIAN Jiashuai,et al.Study on the Current Situation and Influencing Factors of the Disease Burden in Patients with Pulmonary Tuberculosis[J].Journal Press of Health Economics Research,2024,41(09):36.
[3]曹逸钦,张 悦,王艳艳,等.消化系统癌症患者经济毒性的研究进展[J].卫生经济研究,2025,42(02):41.
CAO Yiqin,ZHANG Yue,WANG Yanyan,et al.Research Progress on Financial Toxicity in Patients with Digestive System Cancer[J].Journal Press of Health Economics Research,2025,42(09):41.
[4]梁盛兴,邹俐爱,邱 恒,等.1990—2021年中国归因于高BMI的慢性肾病疾病负担研究[J].卫生经济研究,2025,42(04):42.
LIANG Shengxing,ZOU Liai,QIU Heng,et al.Study on the Disease Burden of Chronic Kidney Disease Attributed to High BMI in China from 1990 to 2021[J].Journal Press of Health Economics Research,2025,42(09):42.
[5]宫琳婧,李佳佳.失智症疾病负担及保障政策的国际比较[J].卫生经济研究,2025,42(09):34.
GONG Linjing,LI Jiajia.International Comparison of the Disease Burden and Protection Policies for Dementia[J].Journal Press of Health Economics Research,2025,42(09):34.
[6]李铭轩,肖晓燕,原 彰.中国归因于高BMI的高血压性心脏病疾病负担研究[J].卫生经济研究,2025,42(11):38.
LI Mingxuan,XIAO Xiaoyan,YUAN Zhang.Study on the Disease Burden of Hypertensive Heart Disease Attributable to High BMI in China[J].Journal Press of Health Economics Research,2025,42(09):38.